Literature DB >> 14185714

[HUMAN INFECTIONS IN CAMBODIA BY THE CHIKUNGUNYA VIRUS OR A CLOSELY RELATED AGENT. 3. EPIDEMIOLOGY].

C CHASTEL.   

Abstract

Entities:  

Keywords:  ARBOVIRUS INFECTIONS; CAMBODIA; EPIDEMIOLOGY

Mesh：

Year:  1964        PMID： 14185714

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


× No keyword cloud information.
  5 in total

1.  Long-Lasting Immune Protection and Other Epidemiological Findings after Chikungunya Emergence in a Cambodian Rural Community, April 2012.

Authors:  Beatriz Galatas; Sowath Ly; Veasna Duong; Kathy Baisley; Kunthy Nguon; Siam Chan; Rekol Huy; Sovann Ly; Sopheak Sorn; Leakhann Som; Philippe Buchy; Arnaud Tarantola
Journal:  PLoS Negl Trop Dis       Date:  2016-01-11

2.  Chikungunya virus emergence in the Lao PDR, 2012-2013.

Authors:  Somphavanh Somlor; Khamsing Vongpayloth; Laure Diancourt; Philippe Buchy; Veasna Duong; Darouny Phonekeo; Pakapak Ketmayoon; Phengta Vongphrachanh; Paul T Brey; Valérie Caro; Yves Buisson; Marc Grandadam
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

Review 3.  Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries.

Authors:  Sarawut Khongwichit; Jira Chansaenroj; Chintana Chirathaworn; Yong Poovorawan
Journal:  J Biomed Sci       Date:  2021-12-02       Impact factor: 8.410

4.  Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community.

Authors:  Heidi Auerswald; Camille Boussioux; Saraden In; Sokthearom Mao; Sivuth Ong; Rekol Huy; Rithea Leang; Malen Chan; Veasna Duong; Sowath Ly; Arnaud Tarantola; Philippe Dussart
Journal:  Emerg Microbes Infect       Date:  2018-02-07       Impact factor: 7.163

Review 5.  Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.

Authors:  Simon-Djamel Thiberville; Nanikaly Moyen; Laurence Dupuis-Maguiraga; Antoine Nougairede; Ernest A Gould; Pierre Roques; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2013-06-28       Impact factor: 5.970
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.